SGS Harrisburg, PA | Heavy Metals Analysis, Lead Testing, Elemental Trace Metals, Inorganic Impurities Analysis
Questions?
Call (717) 697-7536 or Email Us
  • Home
  • About Us
    • The SGS Advantage
    • Our Team
    • News
    • Blog
  • Capabilities
  • Industries
    • Pharmaceuticals
    • Cosmetics
    • Natural Products / Supplements
    • Toxicology
    • Extractables & Leachables
    • Other Industries
  • Quality
    • Overview
    • Client Reviews
    • Case Studies
  • Resources
    • FAQs
    • Choosing a Contract Laboratory
    • Accreditations & Memberships
    • Sample Submittal Form
    • Sales Terms and Conditions
    • SGS Periodic Table
    • ICH Training Materials: 0 – 9
    • When To Submit EI Data To FDA
    • Understanding SGS Analytical Reports
  • Regulations
    • California Proposition 65
    • USP <232> / USP <233> and ICH Q3D
    • FDA GMP/GLP
    • USP <2232>
    • USP <661>
    • USP <1225> / <1226>
    • USP <1660>
  • Contact Us
    • Career Opportunities
Menu
Get a Quote >

ICH Training Materials: Modules 0 – 9

Home / Resources / ICH Training Materials: Modules 0 – 9

Module 0 – Overview.pdf
Module 1 – Developing Acceptable Levels for Other Routes of Administration.pdf
Module 2 – Justification for Exceeding a PDE.pdf
Module 3 – Developing Acceptable Levels for EI not in Q3D.pdf
Module 4 – Considerations for Large Volume Parenterals.pdf
Module 5 – Risk Assessment.pdf
Module 6 – Controls on Elemental Impurities.pdf
Module 7 – Calculations Options.pdf
Module 8-1a – Case Study 1 for PQS_14Jul2016.pdf
Module 8-1b – Case Study 1 for Dossier_14Jul2016.pdf
Module 8-2 – Case Study 2 for PQS_August2016.pdf
Module 8-3 – Case Study 3 for PQS_14Jul2016.pdf
Module 9 – Consolidated FAQs final_14Jul2016.pdf

Dermal Draft guidance – October 2019

SGS Banner Graphic
SGS North America, Inc.
931 North Seventh Street
Harrisburg, PA 17102
(717) 697-7536
Follow Us
  • Facebook
  • Twitter